Nalaganje...
Low-dose subcutaneous immunoglobulin is an effective treatment for autoimmune bullous skin disorders: A case report
Intravenous immunoglobulin is a recognized treatment in recalcitrant autoimmune bullous diseases. Infusions are administered monthly over 1–5 days in the hospital setting and associated with mild to severe infusion-related systemic effects, in part due to the high doses necessary to induce and achie...
Shranjeno v:
| izdano v: | SAGE Open Med Case Rep |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6974749/ https://ncbi.nlm.nih.gov/pubmed/32010445 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050313X19901071 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|